Short Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Increases By 40.0%

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the recipient of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 2,100 shares, an increase of 40.0% from the October 15th total of 1,500 shares. Based on an average trading volume of 16,400 shares, the days-to-cover ratio is currently 0.1 days.

Reviva Pharmaceuticals Stock Up 16.1 %

Shares of Reviva Pharmaceuticals stock traded up $0.03 during trading on Friday, reaching $0.19. 1,888 shares of the company were exchanged, compared to its average volume of 16,501. The business has a 50-day moving average price of $0.13 and a 200-day moving average price of $0.20. Reviva Pharmaceuticals has a twelve month low of $0.07 and a twelve month high of $1.62.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.